Managing ALK Rearranged Lung Cancer

This chapter discusses the management strategies for oligometastatic ALK rearrangement-positive lung cancer, focusing on local therapies like radiation and surgery. It emphasizes the importance of rapid testing and targeted therapies over traditional methods due to better outcomes for patients. The conversation also addresses brain metastases' unique characteristics and highlights the use of lorlatinib, examining patient expectations and dosing strategies.